Literature DB >> 21691099

Pleiotropic functions of the organic solute transporter Ostα-Ostβ.

Nazzareno Ballatori1.   

Abstract

The heteromeric organic solute transporter alpha-beta (Ostα-Ostβ) is expressed at relatively high levels on the basolateral membrane of enterocytes, where it plays a critical role in the intestinal absorption of bile acids and the enterohepatic circulation. However, this transporter is also expressed in nearly all human tissues, including those that are not normally thought to be involved in bile acid homeostasis, indicating that Ostα-Ostβ may have additional roles beyond bile acid transport in these other tissues, or that bile acids and their derivatives are more pervasive than currently envisioned. Emerging data from different laboratories provide support for both of these hypotheses. In particular, recent studies indicate that tissues such as brain and ovary have the capacity to synthesize bile acids or bile acid precursors. In addition, studies examining Ostα-Ostβ substrate specificity have revealed that this transporter can also accept conjugated steroids, including some neurosteroids, and that the transporter is selectively expressed in steroidogenic cells of the brain and adrenal gland, suggesting a novel function for Ostα-Ostβ. The broad tissue expression of Ostα-Ostβ is also consistent with the emerging concept that bile acids and their derivatives act as signaling molecules in diverse tissues. Bile acids activate nuclear receptors such as the farnesoid X receptor (FXR/NR1H4), the pregnane X receptor and the vitamin D receptor, are ligands for a G-protein-coupled bile acid receptor (GPBAR1/TGR5), and can also activate protein kinases A and C as well as mitogen-activated protein kinase pathways. These signaling pathways are present in many tissues and regulate processes such as triglyceride, glucose and energy homeostasis. Note that although FXR and TGR5 are thought to function primarily as bile acid receptors, they are modulated by some other sterols and select lipid metabolites, and are also widely expressed in tissues, indicating a complex interplay among diverse regulatory networks that impact critical cell and organ functions. The present report summarizes the evidence for a pleiotropic role of Ostα-Ostβ in different tissues.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691099      PMCID: PMC3128137          DOI: 10.1159/000324123

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  38 in total

1.  Neurosteroid transport by the organic solute transporter OSTα-OSTβ.

Authors:  Fang Fang; Whitney V Christian; Sadie G Gorman; Mei Cui; Jiaoti Huang; Kim Tieu; Nazzareno Ballatori
Journal:  J Neurochem       Date:  2010-08-12       Impact factor: 5.372

2.  5Alpha-bile alcohols function as farnesoid X receptor antagonists.

Authors:  Tomoko Nishimaki-Mogami; Yosuke Kawahara; Norimasa Tamehiro; Takemi Yoshida; Kazuhide Inoue; Yasuo Ohno; Taku Nagao; Mizuho Une
Journal:  Biochem Biophys Res Commun       Date:  2005-11-14       Impact factor: 3.575

3.  Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate.

Authors:  W Wang; D J Seward; L Li; J L Boyer; N Ballatori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

Review 4.  Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta.

Authors:  Nazzareno Ballatori
Journal:  Exp Biol Med (Maywood)       Date:  2005-11

5.  The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.

Authors:  Paul A Dawson; Melissa Hubbert; Jamie Haywood; Ann L Craddock; Noa Zerangue; Whitney V Christian; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

6.  OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia.

Authors:  Nazzareno Ballatori; Whitney V Christian; Jin Young Lee; Paul A Dawson; Carol J Soroka; James L Boyer; Michael S Madejczyk; Na Li
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

7.  Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta.

Authors:  David J Seward; Albert S Koh; James L Boyer; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

8.  The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain.

Authors:  Verena Keitel; Boris Görg; Hans J Bidmon; Irina Zemtsova; Lina Spomer; Karl Zilles; Dieter Häussinger
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

9.  Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding.

Authors:  Altaf Kassam; Bowman Miao; Peter R Young; Ranjan Mukherjee
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

10.  Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets.

Authors:  Annie Zhao; Jinghua Yu; Jane-L Lew; Li Huang; Samuel D Wright; Jisong Cui
Journal:  DNA Cell Biol       Date:  2004-08       Impact factor: 3.311

View more
  11 in total

1.  β-Subunit of the Ostα-Ostβ organic solute transporter is required not only for heterodimerization and trafficking but also for function.

Authors:  Whitney V Christian; Na Li; Patricia M Hinkle; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 3.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

Review 4.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules.

Authors:  Nazzareno Ballatori; Whitney V Christian; Sadie G Wheeler; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

6.  A novel RARα/CAR-mediated mechanism for regulation of human organic solute transporter-β gene expression.

Authors:  Shuhua Xu; An-Qiang Sun; Frederick J Suchy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-21       Impact factor: 4.052

7.  Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?

Authors:  James E Nelson; Christian L Roth; Laura A Wilson; Katherine P Yates; Bradley Aouizerat; Vicki Morgan-Stevenson; Elizabeth Whalen; Andrew Hoofnagle; Michael Mason; Vivian Gersuk; Matthew M Yeh; Kris V Kowdley
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864

Review 8.  Clinical application of transcriptional activators of bile salt transporters.

Authors:  Anna Baghdasaryan; Peter Chiba; Michael Trauner
Journal:  Mol Aspects Med       Date:  2013-12-12

Review 9.  Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.

Authors:  Kim L Mertens; Andries Kalsbeek; Maarten R Soeters; Hannah M Eggink
Journal:  Front Neurosci       Date:  2017-11-07       Impact factor: 4.677

10.  The Brain Metabolome of Male Rats across the Lifespan.

Authors:  Xiaojiao Zheng; Tianlu Chen; Aihua Zhao; Xiaoyan Wang; Guoxiang Xie; Fengjie Huang; Jiajian Liu; Qing Zhao; Shouli Wang; Chongchong Wang; Mingmei Zhou; Jun Panee; Zhigang He; Wei Jia
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.